Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects
This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect and Relative bioavailability of VC004 Capsules in healthy subjects
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
DRUG: High Dose VC004 Capsules|DRUG: Median Dose VC004 Capsules|DRUG: Low Dose VC004 Capsules
Maximum Observed Plasma Concentration (Cmax), Day1-Day7|Peak time(Tmax), Day1-Day7|Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUCï¼‰, Day1-Day7
This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect and Relative bioavailability of VC004 Capsules in healthy subjects